Endothelin-1 induces vasoconstriction on portal-systemic collaterals of portal hypertensive rats

Hepatology

Volumn 33, Issue 4, 2001, Pages 816-820

  Chan, Che Chang ^a,b   Wang, Sun Sang ^a,b   Lee, Fa Yauh ^a   Chang, Full Young ^a   Lin, Han Chieh ^a   Chu, Chi Jen ^a   Chen, Chien Ting ^a   Huang, Hui Chun ^a   Lee, Shou Dong ^a  

^a Gastroenterology   (China)

^b TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); ENDOTHELIN 1; ENDOTHELIN A RECEPTOR; ENDOTHELIN A RECEPTOR ANTAGONIST; ENDOTHELIN B RECEPTOR; ENDOTHELIN B RECEPTOR ANTAGONIST; INDOMETACIN; N (2,6 DIMETHYLPIPERIDINOCARBONYL) 4 METHYLLEUCYL DEXTRO (1 METHOXYCARBONYLTRYPTOPHANYL) DEXTRO NORLEUCINE; N(G) NITROARGININE; NITRIC OXIDE; PROSTAGLANDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; INCUBATION TIME; MALE; NONHUMAN; PATHOGENESIS; PORTAL HYPERTENSION; PORTAL VEIN BLOOD FLOW; PORTOSYSTEMIC ANASTOMOSIS; PRIORITY JOURNAL; RAT; RECEPTOR INTRINSIC ACTIVITY; TISSUE CULTURE; VASCULAR RESISTANCE; VASOCONSTRICTION; VEIN LIGATION;

EID: 0035082815     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2001.23079     Document Type: Article

References (40)

1. A novel potent vasoconstrictor peptide produced by vascular endothelial cells
2. Endothelin, a novel endothelium-derived peptide: Pharmacological activities, regulation and possible roles in cardiovascular disease
3. The human endothelin family: Three structurally and pharmacologically distinct isopeptides predicted by three separate genes
4. B receptors in isolated rabbit liver
5. Increased expression of endothelin receptors in the vasculature of portal hypertensive rats: Role in splanchnic hemodynamics
6. Occurrence, specific binding sites and functional effects of endothelin in human cardiopulmonary tissue
7. Endothelin receptors: Receptor classification, novel receptor antagonists, and potential therapeutic targets
8. B receptor in endothelial cells: Receptor coupling to nitric oxide synthase
9. Contribution of endogenous generation of endothelin-1 to basal vascular tone
10. Portal pressure, presence of gastroesophageal varices and variceal bleeding
11. Pathophysiology of portal hypertension
12. B receptors
13. Endothelin induced contractility of stellate cells from normal and cirrhotic rat liver: Implications for regulation of portal pressure and resistance
14. Effects of endothelin and vasopressin on portal pressure of rats
15. B receptor antagonist, in portal hypertensive rats
16. Measurement of portal-systemic shunting in the rat by using γ-labeled microspheres
17. Evolution of portal hypertension and mechanisms involved in its maintenance in a rat model
18. Pharmacology of portal-systemic collaterals in portal hypertensive rats: Role of endothelium
19. Effects of vasopression on portal-systemic collaterals of portal hypertensive rats: Role of nitric oxide and prostaglandin
20. A simple and inexpensive membrane "lung" for small organ perfusions
21. A receptor
22. Biochemical and pharmacological profile of a potent and selective endothelin B-receptor antagonist, BQ-788
23. Endothelin-A receptor antagonist prevents acute hypoxia-induced pulmonary hypertension in the rat
24. Role of endothelins in regulation of vascular tone in the in situ perfused rat adrenals
25. Circulating levels of endothelin in cirrhosis
26. The endothelin system. A new target for therapeutic intervention
27. B receptor mediates both vasodilation and vasoconstriction in vivo
28. Vessel- and target cell-specific actions of endothelin-1 and endothelin-3 in rat liver
29. Vasoactive effect of endothelin-1 on rat liver in vivo
30. B receptors in human cirrhosis: Relationship with hepatic hemodynamics
31. Nitric oxide mediates hyporeactivity to vasopressors in mesenteric vessels of portal hypertensive rats
32. ω-nitro-L-arginine ameliorates portal-systemic shunting in portal-hypertensive rats
33. Nitric oxide modulates hepatic vascular tone in normal rat liver
34. Effects of inhibiting nitric oxide biosynthesis on the systemic and splanchnic circulation of rats with portal hypertension
35. Prostacyclin mediates splanchnic vascular response to norepinephrine in portal hypertension
36. Role of prostacyclin in the splanchnic hyperemia contributing to portal hypertension
37. Regulation of endothelin-1 action on the perfused rat liver
38. Enhanced cyclooxygenase-1 expression within the superior mesenteric artery of portal hypertensive rats: Role in the hyperdynamic circulation
39. The relationship between prostacyclin activity and pressure in the portal vein
40. Effects of nitric oxide and cyclooxygenase inhibition on splanchnic hemodynamics in portal hypertension